My current projects use 3D in vitro models to understand the implications of macrophages on immunotherapy effectiveness for treating cancer. In particular, I am interested in harnessing tumor-associated macrophages to augment standard cancer treatment regimens.

I received by B.S. in Biomedical Engineering from the University of Utah in 2016. My research focus was on developing decellularized bone matrices for hematopoietic stem cell differentiation. After undergrad, I came to Cornell and did my M.S. in Biomedical Engineering with Ankur Singh on microfluidic-produced hydrogel models of B cell lymphoma to study tumor heterogeneity. My previous work has driven my passion for immunoengineering and immunotherapy targets for cancer culminating in my current project in the Fischbach group as I pursue a PhD in Biomedical Engineering.

res393[at]cornell.edu